Patch testing and sensitization to multiple drugs.
Jussi Liippo1, Kati Pummi, Ulla Hohenthal
1Department of Dermatology, Turku University Hospital, 20521, Turku, Finland.
Contact Dermatitis
|October 15, 2013
Summary
Drug patch testing helps identify multiple drug sensitizations in patients with suspected allergies. This diagnostic tool is crucial for understanding delayed-type drug reactions and improving patient care.
Area of Science:
- Dermatology
- Allergology
- Clinical Pharmacology
Background:
- Adverse drug reactions present a significant diagnostic challenge in healthcare settings.
- Patch testing is a valuable method for identifying causative agents in suspected allergic drug eruptions.
Observation:
- This study investigated patient cases of multiple delayed-type drug sensitizations using patch testing.
- Eight hundred and eleven patients with suspected drug allergy were included over a nine-year period.
Findings:
- Multiple delayed drug sensitizations were identified in 12% of patients with positive drug patch test results.
- These patients may exhibit recurrent exanthemas or contact dermatitis.
Implications:
- Drug patch testing is effective for diagnosing cutaneous adverse drug reactions when multiple drug culprits are suspected.
- Identifying multiple drug sensitizations aids in managing patients with delayed drug allergies and associated dermatological conditions.
More Related Videos
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
01:16Drug toxicity: Idiosyncratic Reactions
232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
01:20Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
01:24Drug Toxicity: Dose-Dependent Reactions
245
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245
01:24Drug Toxicity: Risk factors
250
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
250
01:30Drug toxicity: Drug–Drug Interaction
437
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
437